-Charles W Francis Researcher Activity Profile

Research Author Detailed Information 

Charles W Francis Publication Rate By Year

Charles W Francis has published 1 paper(s) in 1990, 1 paper(s) in 2002, 1 paper(s) in 2003, 1 paper(s) in 2006, 6 paper(s) in 2007, 6 paper(s) in 2008, for a total of 16 research publications in total.

Charles W Cw Francis Author Information

LAST NAME: francis

FIRST NAME: Charles W

INITIALS: cw

AFFILIATION:

Papers

Charles W Francis's Publication Record

1. The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands. Year Published: 2006
Department of Environmental Medicine and the Lung Biology and Disease Program, University of Rochester, School of Medicine and Dentistry, Box 850, 601 Elmwood Avenue, Rochester, NY 14642, USA.
2. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Year Published: 2007
3. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Year Published: 2007
James P. Wilmot Cancer Center, Department of Medicine, University of Rochester, Rochester, New York 14642, USA. alok_khorana@URMC.rochester.edu
4. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Year Published: 2007
Duke University Medical Center, University of Rochester Medical Center, Rochester, USA.
5. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Year Published: 2007
James P. Wilmot Cancer Center and the Department of Medicine, University of Rochester, Rochester, New York 14642, USA. alok_khorana@URMC.rochester.edu
6. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Year Published: 2007
Duke University Medical Center, University of Rochester Medical Center, Rochester, USA.
7. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Year Published: 2007
James P. Wilmot Cancer Center and the Department of Medicine, University of Rochester, Rochester, New York 14642, USA. alok_khorana@URMC.rochester.edu
8. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). Year Published: 2008
Hematology/Oncology Division, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
9. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Year Published: 2008
University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 850, Rochester, New York, USA 14642. E-mail: richard_phipps@urmc.rochester.edu.
10. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Year Published: 2008
University of Rochester Medical Center, Environmental Medicine, Rochester, New York 14642, USA .
11. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). Year Published: 2008
Hematology/Oncology Division, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. abha_sahni@urmc.rochester.edu
12. Consultations on patients with venous or arterial diseases. Year Published: 2003
University of Rochester Medical Center, Rochester, NY 14642-0001, USA.
13. Randomized prospective study comparing routine versus selective use of sonography of the complete calf in patients with suspected deep venous thrombosis. Year Published: 2002
Department of Radiology, University of Rochester Medical Center, 601 Elmwood Ave., Box 648, Rochester, NY 14642, USA.
14. Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. Year Published: 1990
Department of Radiology, University of Rochester Medical Center, NY 14642.
15. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Year Published: 2008
University of Rochester Medical Center, Environmental Medicine, Rochester, New York 14642, USA .
16. The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. Year Published: 2008
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 608, Rochester,NY 14642,USA.